Home/ Stocks/ CAMP

CAMP4 Therapeutics Corporation Common Stock

CAMP XNAS

$4.24 -0.26 (-5.78%) ▼ 15-min delayed

Open

$4.58

High

$4.60

Low

$4.15

Volume

95.1K

Market Cap

$282.25M

About CAMP4 Therapeutics Corporation Common Stock

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 48 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.29M	$-18,331,000	$-0.32
FY 2025	$3.50M	$-80,403,000	$-2.65
Q3 2025	$795.0K	$-15,099,000	$-0.55
Q2 2025	$1.50M	$-12,587,000	$-0.62

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for CAMP yet. Check out our latest market news or earnings calendar.

Get CAMP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CAMP4 Therapeutics Corporation Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.